Vita Life Sciences Limited (ASX:VLS)

Australia flag Australia · Delayed Price · Currency is AUD
2.590
+0.070 (2.78%)
At close: Mar 25, 2026
Market Cap137.39M +28.9%
Revenue (ttm)93.27M +17.3%
Net Income10.44M +18.8%
EPS0.18 +16.2%
Shares Out54.52M
PE Ratio13.73
Forward PEn/a
Dividend0.14 (5.56%)
Ex-Dividend DateMar 27, 2026
Volume4,699
Average Volume24,616
Open2.570
Previous Close2.520
Day's Range2.570 - 2.620
52-Week Range1.700 - 2.840
Beta0.55
RSI53.44
Earnings DateFeb 24, 2026

About Vita Life Sciences

Vita Life Sciences Limited, a healthcare company, engages in formulating, packaging, distributing, and selling vitamins and supplements in Australia, Singapore, Malaysia, Thailand, Vietnam, Indonesia, and China. The company offers various minerals, herbs, and superfoods. It markets its products through pharmacies and health food channels under the Herbs of Gold, VitaHealth, and VitaScience brands. The company was founded in 1947 and is headquartered in Mascot, Australia. [Read more]

Sector Healthcare
Founded 1947
Employees 350
Stock Exchange Australian Securities Exchange
Ticker Symbol VLS
Full Company Profile

Financial Performance

In 2025, Vita Life Sciences's revenue was 93.27 million, an increase of 17.31% compared to the previous year's 79.51 million. Earnings were 10.44 million, an increase of 18.80%.

Financial Statements